Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-001 - Clinicopathological Characteristics of NSCLC Patients with Nivolumab-Induced Pneumonitis
09:30 - 09:30 | Presenter: Nobuyuki Koyama
- Abstract
Loading... -
+
P2.07-002 - Drug-Related Pneumonitis in Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Commercial PD-1 Inhibitors
09:30 - 09:30 | Presenter: Mizuki Nishino | Author(s): A.E. Adeni, H. Hatabu, C.A. Lydon, T. Hida, F..S. Hodi, M.M. Awad
- Abstract
Loading... -
+
P2.07-003 - Nivolumab for Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Hironori Yoshida | Author(s): Y.H. Kim, H. Ozasa, H. Nagai, Yuichi Sakamori, T. Tsuji, T. Nomizo, Tomoko Funazo, Yuto Yasuda, T. Hirai
- Abstract
Loading... -
+
P2.07-004 - Immune-Related Adverse Events (irAEs) of Nivolumab Predicts Clinical Benefit in Advanced Lung Cancer Patients
09:30 - 09:30 | Presenter: Yukihiro Toi | Author(s): S. Sugawara, Y. Kawashima, T. Aiba, K. Tsurumi, K. Suzuki, H. Shimizu, J. Sugisaka, H. Ono, Y. Domeki, S. Kawana, R. Saito, K. Terayama, A. Nakamura, S. Yamanda, Y. Kimura, Y. Honda
- Abstract
Loading... -
+
P2.07-005 - Impact of Baseline Leptomeningeal and Brain Metastases on Immunotherapy Outcomes in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
09:30 - 09:30 | Presenter: Laura Mezquita | Author(s): C. Henon, E. Auclin, S. Ammari, C. Caramella, Cecile Le Pechoux, A. Botticella, David Planchard, A. Gazzah, R. Ferrara, J. Lahmar, G. Martinez-Bernal, J. Adam, J. Soria, Benjamin Besse
- Abstract
Loading... -
+
P2.07-006 - Irinotecan Augmented Anti-Tumor Activity of Anti-PD-L1 through Enhancing CD8 Proliferation Regardless of Its Hematotoxicity
09:30 - 09:30 | Presenter: Toshiki Iwai | Author(s): M. Sugimoto, D. Wakita, K. Yorozu, M. Kurasawa, K. Yamamoto
- Abstract
Loading... -
+
P2.07-007 - Retrospective Analysis of Antitumor Effects and Biomarkers of Nivolumab in NSCLC Patients with EGFR Mutations
09:30 - 09:30 | Presenter: Satoshi Watanabe | Author(s): H. Tanaka, K. Nozaki, M. Sato, M. Arita, Y. Mishina, Satoshi Shoji, K. Ichikawa, R. Kondo, T. Sakagami, T. Koya, T. Kikuchi
- Abstract
Loading... -
+
P2.07-008 - Does PD-L1 Expression of the Archive Surgical Specimen of Primary Tumor Predict the Sensitivity of Recurrence to Nivolumab in Patients with NSCLC?
09:30 - 09:30 | Presenter: Yuki Shiina | Author(s): H. Suzuki, Yuichi Sakairi, H. Tamura, H. Wada, T. Fujiwara, Takahiro Nakajima, M. Chiyo, M. Ota, S. Ota, Y. Nakatani, I. Yoshino
- Abstract
Loading... -
+
P2.07-009 - Monitoring Nivolumab Binding as a Method to Clarify the Residual Therapeutic Effects in Previously Treated Lung Cancer Patients
09:30 - 09:30 | Presenter: Akio Osa | Author(s): S. Koyama, T. Uenami, K. Fujimoto, Y. Naito, H. Hirata, T. Takimoto, I. Nagatomo, Y. Takeda, H. Kida, M. Mori, T. Kijima, A. Kumanogoh
- Abstract
Loading... -
+
P2.07-010 - Impact of Clinicopathological Features on the Efficacy of PD-1/PD-L1 Inhibitors in Patients with Previously Treated Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Tao Jiang | Author(s): M. Qiao, Caicun Zhou
- Abstract
Loading... -
+
P2.07-011 - Long Follow up from Phase I Study of Nivolumab and Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Shintaro Kanda | Author(s): Yuichiro Ohe, Y. Matsumoto, S. Murakami, Yasushi Goto, Hidehito Horinouchi, Y. Fujiwara, H. Nokihara, N. Yamamoto, T. Yamamoto, T. Tamura
- Abstract
Loading... -
+
P2.07-012 - Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Martin Früh | Author(s): S. Schmid, S. Diem, M. Krapf, Q. Li, L. Flatz, S. Leschka, L. Desbiolles, D. Klingbiel, W. Jochum
- Abstract
Loading... -
+
P2.07-013 - Efficacy and Safety of Nivolumab in Non-Small Cell Lung Cancer with Preexisting Interstitial Lung Disease
09:30 - 09:30 | Presenter: Osamu Kanai | Author(s): Y.H. Kim, Y. Demura, M. Kanai, K. Fujita, Hironori Yoshida, M. Akai, T. Mio, T. Hirai
- Abstract
Loading... -
+
P2.07-014 - Immune Checkpoint Inhibitors for Brain Metastases of Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Hironori Ashinuma | Author(s): M. Shingyoji, T. Iuchi, Y. Yoshida, T. Setoguchi, Y. Hasegawa, T. Sakaida
- Abstract
Loading... -
+
P2.07-015 - Reviving Chemotherapy Sensitivity after Anti-CCR4 mAb (Mogamulizumab) Treatment in Lung Cancer Patients
09:30 - 09:30 | Presenter: Koji Kurose | Author(s): Yoshihiro Ohue, M. Isobe, S. Suzuki, H. Wada, R. Ueda, E. Nakayama, M. Oka
- Abstract
Loading... -
+
P2.07-016 - Inmunotherapy: Which Is More Important, Choosing Patients Who Will Respond or Identifying Those Who Will Die Early?
09:30 - 09:30 | Presenter: Inmaculada Ramos García | Author(s): M. Berciano, M. Dominguez, J. Baena, A. Godoy, L. Pérez, L. Galvez, M. Robles, T. Redondo, C. Quero, M.I. Sáez, M. Trigo
- Abstract
Loading... -
+
P2.07-017 - Association between Thyroid Dysfunction and Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Received Nivolumab
09:30 - 09:30 | Presenter: Tomoko Funazo | Author(s): H. Ozasa, T. Nomizo, Yuto Yasuda, T. Tsuji, Hironori Yoshida, Yuichi Sakamori, H. Nagai, T. Hirai, Y.H. Kim
- Abstract
Loading... -
+
P2.07-018 - Correlation of Clinical Response and XAGE1 Immunity in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Yoshihiro Ohue | Author(s): K. Kurose, M. Isobe, Minoru Fukuda, E. Nakayama, M. Oka
- Abstract
Loading... -
+
P2.07-019 - Role of Anti-Angiogenesis on the Prognosis in Advanced Non-Small Cell Lung Cancer Who Are Treated with Immunotherapy
09:30 - 09:30 | Presenter: Takefumi Komiya | Author(s): C.H. Huang, P. Neupane, P. Chalise
- Abstract
Loading... -
+
P2.07-020 - Distinct Immune Status in Patients with Adenocarcinoma and Squamous Cell Carcinoma: Implication for Immunotherapy of NSCLC
09:30 - 09:30 | Presenter: Nada Hradilova | Author(s): Ond?ej Palata, L. Sadilova, D. Myšíková, H. Mrazkova, R. Lischke, R. Špíšek, I. Adkins
- Abstract
Loading... -
+
P2.07-021 - A Checkpoint Molecule B7-H3 as a Novel Immune Therapy Target for Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Kimio Yonesaka | Author(s): K. Kudoh, S. Takamura, H. Sakai, R. Kato, K. Haratani, T. Takahama, K. Tanaka, Hidetoshi Hayashi, H. Kaneda, M. Takeda, O. Maenishi, M. Yamato, M. Miyazawa, Kazuto Nishio, Kazuhiko Nakagawa
- Abstract
Loading... -
+
P2.07-022 - Inflammatory Cytokine Induction after Anti-PD-1 Ab Administration Relates to the Efficacy and Safety in Patients with Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Yuichi Ozawa | Author(s): Y. Amano, T. Koyauchi, T. Kakutani, Y. Sato, H. Hasegawa, T. Matsui, M. Tanahashi, H. Niwa, K. Yokomura, T. Suda
- Abstract
Loading... -
+
P2.07-023 - Safety of Immune Checkpoint Inhibitors in Patients with Preexisting Autoimmune Disease
09:30 - 09:30 | Presenter: Margaux Geier | Author(s): A. Tison, G. Quéré, L. Misery, T. Lesimple, M. Marcq, S. Martinez, F. Brunet-Possenti, S. Mansard, N. Beneton, M. Lambert, C. Rogé, O. Zehou, F. Aubin, S. Maanaoui, C. Scalbert, D. Giacchero, N. Kramkimel, F. Skowron, A. Pham-Ledard, D. Cornec, M. Kostine
- Abstract
Loading... -
+
P2.07-024 - Real-World Data of Nivolumab for Previously Treated Non-Small Cell Lung Cancer Patients in Japan: A Multicenter Retrospective Cohort Study
09:30 - 09:30 | Presenter: Daichi Fujimoto | Author(s): H. Yoshioka, Yuki Kataoka, Y.H. Kim, K. Tomii, T. Ishida, M. Hirabayashi, S. Hara, M. Ishitoko, Y. Fukuda, M.H. Hwang, N. Sakai, M. Fukui, H. Nakaji, T. Hirai
- Abstract
Loading... -
+
P2.07-025 - Increased Antitumor Response to Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Song Ee Park | Author(s): Y. Kim, H.K. Kim, H. Lee, J.H. Cho, S.W. Lim, S. Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn, Jong-Mu Sun
- Abstract
Loading... -
+
P2.07-026 - Nivolumab in Non-Small Cell Lung Cancer (NSCLC): Facing the Reality
09:30 - 09:30 | Presenter: Sivan Shamai | Author(s): O. Merimsky
- Abstract
Loading... -
+
P2.07-027 - Efficacy and Safety of Nivolumab Therapy for Advanced NSCLC in the Expanded Access Named Patient Program in Taiwan
09:30 - 09:30 | Presenter: Bin-Chi Liao | Author(s): C. Chiang, P. Chen, Y. Shen, W. Chen, J. Hung, K. Rau, C. Lai, C. Chen, Y. Kuo, Y. Tsai, S. Wu, C. Lin, Yu-Feng Wei, M. Wu, S. Tsao, T.C. Tsao, C. Ho, Y. Feng, C. Tsao, M. Lin, I. Chong, T. Hsia, N. Chu, Y. Chen, C. Yu, James Chih-Hsin Yang
- Abstract
Loading... -
+
P2.07-028 - Efficacy and Safety of Nivolumab in Non-Small Cell Lung Cancer Patients Who Relapse after Thoracic Radiotherapy
09:30 - 09:30 | Presenter: Teppei Yamaguchi | Author(s): Y. Oya, Y. Kagawa, H. Furuta, N. Watanabe, J. Shimizu, Y. Horio, T. Uemura, S. Morikawa, K. Imaizumi, T. Hida
- Abstract
Loading... -
+
P2.07-029 - CheckMate 169: Safety/Efficacy of Nivolumab in Canadian Pretreated Advanced NSCLC (including Elderly and PS 2) Patients
09:30 - 09:30 | Presenter: Rosalyn J. Juergens | Author(s): Q. Chu, J. Rothenstein, F. De Angelis, S. Banerji, K. Marquis, D. Sauciuc, P. Begin, N. Finn, Vera Hirsh, A. Faghih, J. Yun, A. Li, A. Acevedo, L. Musallam, P.K. Cheema
- Abstract
Loading... -
+
P2.07-030 - Real Life Second-Line Nivolumab in Advanced Non-Small-Cell-Lung Cancer: A French Observational Multicenter Study of 259 Patients
09:30 - 09:30 | Presenter: Margaux Geier | Author(s): R. Descourt, G. Quéré, R. Corre, G. Leveiller, R. Lamy, E. Goarant, J. Bizec, C. Bernier, F. Couturaud, G. Robinet
- Abstract
Loading... -
+
P2.07-031 - Relationship between Clinical Factors and the Expression of Programmed Death Ligand 1 in Lung Cancer
09:30 - 09:30 | Presenter: Yasuhiro Kato | Author(s): K. Watanabe, J. Kashima, K. Hashimoto, A. Fukuda, A. Mitsuhashi
- Abstract
Loading... -
+
P2.07-032 - Outcomes of Nivolumab in Metastatic NSCLC Patients via the Access Program Across Multiple Tertiary Oncology Centres.
09:30 - 09:30 | Presenter: Kenneth Obyrne | Author(s): K.E. Roberts, R. Mason, D. Vagenas, Z. Lwin, B. Hughes, V. Jain
- Abstract
Loading... -
+
P2.07-033 - Anti-PD1-Induced Rotator Cuff Injury: A Case Series
09:30 - 09:30 | Presenter: Kenneth Obyrne | Author(s): K.E. Roberts, Q. Tran, P. Eliadis, B. Hughes
- Abstract
Loading... -
+
P2.07-034 - Health Status in Patients with Small-Cell Lung Cancer Treated with Nivolumab Alone or Combined with Ipilimumab: CheckMate 032
09:30 - 09:30 | Presenter: D. Ross Camidge | Author(s): A. Ardizzoni, A.F. Farago, A. Atmaca, Emiliano Calvo, F. Taylor, B. Bennett, G. Selvaggi, A. Pieters, J.R. Penrod, Yong Yuan
- Abstract
Loading... -
+
P2.07-035 - Correlation Between Immune-Related Adverse Events and Efficacy in Non-Small Cell Lung Cancer Treated with Nivolumab
09:30 - 09:30 | Presenter: Koichi Sato | Author(s): H. Akamatsu, M. Eriko, S. Sakaki, K. Kanai, A. Hayata, N. Tokudome, K. Akamatsu, Y. Koh, H. Ueda, M. Nakanishi, Nobuyuki Yamamoto
- Abstract
Loading... -
+
P2.07-036 - Appropriate Use of Immune Checkpoint Inhibitors in Advanced NSCLC: Effectiveness of Unique Case-Based Education on Clinical Decision-Making
09:30 - 09:30 | Presenter: Tara Herrmann | Author(s): E. Hamarstrom, H. Kadkhoda, L. Wiggins, M.L. Johnson, J. Weiss
- Abstract
Loading... -
+
P2.07-037 - Developing a Predictive Clinical Outcome Model for Advanced Non-Small Cell Lung Cancer Patients
Receiving Nivolumab09:30 - 09:30 | Presenter: Wungki Park | Author(s): D. Kwon, D. Saravia, A. Desai, J. Warsch, F. Vargas, M. El Dinali, R. Elias, Y.K. Chae, D.W. Kim, S. Warsch, A. Ishkanian, C. Ikpeazu, R. Mudad, Gilberto Lopes, M. Jahanzeb
- Abstract
Loading... -
+
P2.07-038 - Thyroid Dysfunction Arising During KEYNOTE-001 Associated with Improved Efficacy of Pembrolizumab in NSCLC Patients at UCLA
09:30 - 09:30 | Presenter: Aaron Lisberg | Author(s): K. Bornazyan, J. Madrigal, J.L. Bui, J. Carroll, C. Adame, J. Hunt, H. Lu, Z. Noor, A. Cummings, Jonathan W. Goldman, Edward Brian Garon
- Abstract
Loading... -
+
P2.07-039 - Nivolumab Experience in Patients with Previously Treated Advanced Non Small Cell Lung Cancer (NSCLC) in Toledo, Spain
09:30 - 09:30 | Presenter: Antonio Irigoyen Medina | Author(s): E. Martinez Moreno, K. Martinez Barroso, M. Borregon Rivilla, R. Alvarez Cabellos, J.D. Cardenas, J. Andrade Santiago, I. Burgueño Lorenzo, B. Trujillo Alba, J.I. Chacon Lopez-Muñiz
- Abstract
Loading... -
+
P2.07-040 - Pre-Treatment Tumor Volume in Non-Small Cell Lung Cancer (NSCLC) as a Predictor of Response to PD-1 Inhibitors
09:30 - 09:30 | Presenter: Misako Nagasaka | Author(s): M. Crosby, N. Thummala, J. Abrams, A. Sukari
- Abstract
Loading... -
+
P2.07-041 - Immuno-Related Cutaneous Adverse Events (IRcutAEs) in Patients (P) with Advanced NSCLC: A Single-Institution Prospective Study
09:30 - 09:30 | Presenter: Enric Carcereny | Author(s): A. Boada, R. Blanco, R. Marsé, N. Rivera, Margarita Majem, J. Terrasa, Y. García, J. Coves, A. Estival, E. Dalmau, L. Vila, P. Riera, T. Morán
- Abstract
Loading... -
+
P2.07-042 - Feasibility Study of Nivolumab and Docetaxel in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Tsuneo Shimokawa | Author(s): Y. Nakamura, S. Iwasawa, K. Miyazaki, T. Yamanaka, Y. Takiguchi, Hiroaki Okamoto
- Abstract
Loading... -
+
P2.07-043 - Efficacy and Safety of Anti-PD-1 Antibody as the First Line Treatment in Elderly Patient with Advanced Lung Squamous Cell Carcinoma: A Case Report
09:30 - 09:30 | Presenter: Hua min Shi | Author(s): F.Y. Xing
- Abstract
Loading... -
+
P2.07-044 - Thyroid Disfunction in Advanced NSCLC Patients Treated with Nivolumab out of Clinical Trial: A Real-World Data Analysis
09:30 - 09:30 | Presenter: Ramon Palmero | Author(s): J.C. Ruffinelli, E. Alanya, J.A. Marin, M. Ferrer, M. Jove, C. Mesia, M. Arellano, I. Brao, F. Cardenal, I. Peiro, Ernest Nadal
- Abstract
Loading... -
+
P2.07-045 - A Retrospective Analysis of Nivolumab-Related Pneumonitis in Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Shuhei Tsujino | Author(s): T. Ikeda, Hirokazu Taniguchi, M. Shimada, H. Gyoutoku, H. Senju, H. Yamaguchi, K. Nakatomi, Minoru Fukuda, H. Mukae
- Abstract
Loading... -
+
P2.07-046 - Nivolumab Exerts Remarkable Antitumor Activity in NSCLC After an Immune-Modulating Biochemotherapy Regimen
09:30 - 09:30 | Presenter: Pierpaolo Correale | Author(s): P. Pastina, V. Nardone, C. Botta, S. Croci, D. Davì, P. Tini, G. Battaglia, L. Sebaste, T. Carfagno, S.F. Carbone, V. Ricci, R. Giannicola, P. Tagliaferri, L. Pirtoli
- Abstract
Loading... -
+
P2.07-047 - Poor Performance Status and BRAF Mutation Predict Grade 3-5 Immune-Related Adverse Events in Pts with Advanced NSCLC
09:30 - 09:30 | Presenter: Yan Wang | Author(s): Jinpeng Shi, W. Li, G. Gao, Shengxiang Ren, Caicun Zhou
- Abstract
Loading... -
+
P2.07-048 - Immunotherapy vs. Targeted Therapy - Who Wins? A Case Series
09:30 - 09:30 | Presenter: Inbar Finkel | Author(s): Nir Peled
- Abstract
Loading... -
+
P2.07-049 - Early Clinical Predictors of Progressive Disease or Non-Response to PD-1/PD-L1 Inhibitors in Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: David P Walder | Author(s): R. Kumar, M. Brandao, N. Joharatnam, J. Pealing, A.R. Minchom, C. Milner-Watts, S.Y. Moorcraft, F. Turkes, N. Yousaf, J. Bhosle, Sanjay Popat, Mary Obrien
- Abstract
Loading... -
+
P2.07-050 - Impact of Steroid Use for Immune Related Adverse Events on Outcomes in Non-Small Cell Lung Cancer (NSCLC) Treated with Checkpoint Inhibitors
09:30 - 09:30 | Presenter: Neil J Shah | Author(s): W.J. Kelly, B. Ma, J. Puthiamadathil, M.T. Serzan, Y. Zhou, M. Tan, D. Subramaniam, Giuseppe Giaccone, S.V. Liu
- Abstract
Loading... -
+
P2.07-051 - Immune Checkpoint Associated Cardiotoxicity: An Update
09:30 - 09:30 | Presenter: Zin War Mynt | Author(s): A. Chauhan, S. Arnold, B. Grant, L.B. Anthony
- Abstract
Loading... -
+
P2.07-052 - Detection of KRAS Mutation in Blood Predicts Favorable Response to Immunotherapy in NSCLC
09:30 - 09:30 | Presenter: Martin Frederik Dietrich | Author(s): B. Hunis, Luis E Raez
- Abstract
Loading... -
+
P2.07-053 - A Case of Small Cell Lung Cancer Complicated During Nivolumab Administration as Second Line Treatment for Squamous Cell Lung Cancer
09:30 - 09:30 | Presenter: Tomoki Kimura | Author(s): Y. Kondoh, K. Kataoka, T. Matsuda, T. Yokoyama
- Abstract
Loading... -
+
P2.07-054 - Cost-Effectiveness of Pembrolizumab as First-Line Therapy for Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Pedro Aguiar Jr | Author(s): M. Georgieva, J.P. Lima, B. Haaland, Gilberto Lopes
- Abstract
Loading... -
+
P2.07-055 - Indirect Comparison between Immune-Checkpoint Inhibitors for 2nd Line Non-Small Cell Lung Cancer – a Network Meta-Analysis
09:30 - 09:30 | Presenter: Pedro Aguiar Jr | Author(s): P. Tan, B. Haaland, Gilberto Lopes
- Abstract
Loading... -
+
P2.07-056 - SAKK 16/14 – Perioperative Anti-PD-L1 Antibody Durvalumab in Patients with Stage IIIA(N2) Non-Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Sacha I Rothschild | Author(s): A. Zippelius, Spasenija Savic, M. Gonzalez, Walter Weder, A. Xyrafas, C. Rusterholz, M. Pless
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.07-058 - First-In-Human Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, for Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Julie R Brahmer | Author(s): M.L. Johnson, M.M. Awad, A. Rajan, A.J. Allred, R.E. Knoblauch, E. Zudaire, M.V. Lorenzi, R. Hassan
- Abstract
Loading... -
+
P2.07-059 - Phase I Trial of Gene Mediated Cytotoxic Immunotherapy (GMCI) for Malignant Pleural Effusion (MPE) and Malignant Pleural Mesothelioma (MPM)
09:30 - 09:30 | Presenter: Daniel H. Sterman | Author(s): A.R. Haas, S. Metzger, L.K. Aguilar, E. Aguilar-Cordova, A. Manzanera, G. Gomez, S. Albelda, E. Alley, T. Evans, R.B. Cohen, Joshua Michael Bauml, Corey J Langer, C. Aggarwal
- Abstract
Loading... -
+
P2.07-060 - Response Assessment and Subgroups Analysis According to the Lung Immune Prognostic Index (LIPI) for Immunotherapy in Advanced NSCLC Patients
09:30 - 09:30 | Presenter: Laura Mezquita | Author(s): E. Auclin, Roberto Ferrara, C. Caramella, M. Charrier, J. Remon, David Planchard, S. Ponce, Luis Paz-Ares, J. Lahmar, L. Leroy, C. Audigier-Valette, J. Zeron-Medina, Pilar Garrido, G. Zalcman, Julien Mazieres, J. Adam, N. Chaput, J. Soria, Benjamin Besse
- Abstract
Loading... -
+
P2.07-061 - Nivolumab for Patients with Non-Small Cell Lung Carcinoma in Patients with Progression to One or More Lines of Chemotherapy in Mexican Population
09:30 - 09:30 | Presenter: Jeronimo Rafael Rodriguez-Cid | Author(s): D. Bonilla-Molina, L. Martínez-Barreda, J. Díaz-Rico, P. Arellanes-Herrera, E. Del Olmo Gil, J.C. Chagoya-Bello, J.A. Alatorre Alexander
- Abstract
Loading... -
+
P2.07-062 - PIVOT-02: Phase 1/2 Study of NKTR‐214 and Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumor Malignancies
09:30 - 09:30 | Presenter: Vassiliki A Papadimitrakopoulou | Author(s): N.M. Tannir, C. Bernatchez, C.L. Haymaker, S.E. Bentebibel, B.D. Curti, M.K.K. Wong, I. Gergel, M.A. Tagliaferri, J. Zalevsky, U. Hoch, S. Aung, M. Imperiale, D.C. Cho, S.S. Tykodi, I. Puzanov, H.M. Kluger, M.E. Hurwitz, P. Hwu, M. Sznol, A. Diab
- Abstract
Loading... -
+
P2.07-062a - Single Institutional Experience of the Use of PD-1 Inhibitors to Non-Small Cell Lung Cancer Patients with Preexisting Autoimmune Diseases
09:30 - 09:30 | Presenter: Mehmet Altan | Author(s): F. Fossella, Jianjun Zhang, L. Lacerda Landry, E. Roarty, J. Roth, Stephen Swisher, John V Heymach
- Abstract
Loading... -
+
P2.07-062b - DNA Damage Repair Targeting Upregulates PD-L1 Level and Potentiates the Effect of PD-L1 Blockade in Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Triparna Sen | Author(s): L. Chen, B..L. Rodriguez, C.M. Gay, L. Li, Y. Yang, Y. Fan, B. Glisson, J. Wang, H. Piwnica-Worms, Julien Sage, John V Heymach, Don Lynn Gibbons, L.A. Byers
- Abstract
No abstract available for this presentation
-
+
P2.07-062c - A Phase II Study of BGB324 in Combination with Pembrolizumab in Patients with Previously Treated Advanced Lung Adenocarcinoma
09:30 - 09:30 | Presenter: M. Yule | Author(s): K. Wnuk-Lipinska, K. Davidsen, M. Blø, A. Engelsen, J. Kang, L. Hodneland, K. Aguilera, E. Milde Nævdal, A. Boniecka, O. Straume, S. Chouaib, R.A. Brekken, G. Gausdal, J. Lorens
- Abstract
No abstract available for this presentation
-
+
P2.08 - Locally Advanced Nsclc
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Locally Advanced NSCLC
-
+
P2.08-001 - Hand Grip Strength Is an Independent Prognostic Factor for Mortality in Patients with NSCLC Undergoing Radiotherapy
09:30 - 09:30 | Presenter: Dirk K De Ruysscher | Author(s): Chris Burtin, J. Bezuidenhout, M.A. Spruit
- Abstract
Loading... -
+
P2.08-002 - A Nomogram for Predicting Underlying Beneficiaries for Resectable IIIA/N2 NSCLC Patients
09:30 - 09:30 | Presenter: Chao Zhang | Author(s): Y. Chen, H. Zhai, X. Yang, Yi-Long Wu, W. Zhong
- Abstract
Loading... -
+
P2.08-003 - An Audit of Concurrent Chemoradiotherapy for Non-Small Cell Lung Cancer at the Leeds Cancer Centre (LCC)
09:30 - 09:30 | Presenter: Katy Louise Clarke | Author(s): F. Sun, O. Coen, E. Appleton, A. Zeniou, K.N. Franks, M. Snee, P. Dickinson, P. Jain
- Abstract
Loading... -
+
P2.08-004 - Pathologic Complete Response as an Independed Prognostic Factor in Patients with Locally Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Waldemar Schreiner | Author(s): W. Dudek, R. Fietkau, H. Sirbu
- Abstract
Loading... -
+
P2.08-005 - Salvage Lung Surgery Following Definitive Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Waldemar Schreiner | Author(s): W. Dudek, R. Fietkau, H. Sirbu
- Abstract
Loading... -
+
P2.08-006 - Immunological Biomarkers Characterization in Locally Advanced Non-Small Cell Lung Cancer Treated with Concurrent Chemo-Radiotherapy
09:30 - 09:30 | Presenter: Ernest Nadal | Author(s): M. Saigi, N. Baixeras, A. Rullan, M.A. Bergamino Sirvén, A. Navarro-Martin, M. Arnaiz, J.C. Ruffinelli, C. Mesia, Ramon Palmero, S. Padrones, F. Cardenal, Montse Sanchez-Cespedes
- Abstract
Loading... -
+
P2.08-007 - Five-Year Results of Concurrent Chemotherapy and Isotoxic Radiotherapy Dose-Escalation with IMRT in Stage III NSCLC (NCT01166204)
09:30 - 09:30 | Presenter: Dirk K De Ruysscher | Author(s): B. Reymen, G. Bootsma, Anne-Marie C. Dingemans, W. Geraedts, C. Pitz, W. Van Elmpt, M. Oellers, A. Van Baardwijk, R. Wanders, J. Van Loon
- Abstract
Loading...
-
+
P2.09 - Mesothelioma
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Mesothelioma
-
+
P2.09-001 - Effects of Tumor Burden Reduction on Survival in Epithelioid Pleural Mesothelioma
09:30 - 09:30 | Presenter: Aaron S. Mansfield | Author(s): T. Peikert, N. Vogelzang, J. Symanowski
- Abstract
Loading... -
+
P2.09-001a - TNM or Tumor Volume for Predicting Prognosis in Malignant Pleural Mesothelioma: Still an Open Debate
09:30 - 09:30 | Presenter: Marina Chiara Garassino | Author(s): M. Imbimbo, C. Proto, S. Mallone, D. Signorelli, F.G. Greco, G. Calareso, L. Botta, G. Lo Russo, M. Vitali, G. Corrao, G. Galli, M. Ganzinelli, N. Zilembo, Ugo Pastorino, A. Trama
- Abstract
Loading... -
+
P2.09-002 - Prevalence and Survival of Malignant Pleural Mesothelioma Patients Treated in a Single Brazilian Cancer Center
09:30 - 09:30 | Presenter: V.C. Cordeiro De Lima | Author(s): João Navarro Reolon, A.B.A. Costa, G. Venturi, J.L. Gross, Helano Carioca Freitas, D.B. Sales
- Abstract
Loading... -
+
P2.09-003 - Dissecting the Immune Environment in Malignant Pleural Mesothelioma: Results from a Prospective Assessment
09:30 - 09:30 | Presenter: Silvia Novello | Author(s): C. Riganti, M. Pradotto, L. Righi, C. Marchiò, E. Capelletto, C. Buttigliero, L. Costardi, J. Kopecka, P. Bironzo, Enrico Ruffini, Giorgio Vittorio Scagliotti
- Abstract
Loading... -
+
P2.09-004 - PD-L1 Protein Expression Is Negative Prognostic Factor in Malignant Pleural Mesothelioma in Central Europe
09:30 - 09:30 | Presenter: Luka Brcic | Author(s): Marko Jakopovic, I. Kern, K. Mohorcic, S. Seiwerth, Michael Grusch, M. Rajer, A. Buder, T. Klikovits, V. Laszlo, B. Dome, B. Hegedus, W. Klepetko, V. Kolek, Robert Pirker, Mir Alireza Hoda, Martin Filipits
- Abstract
Loading... -
+
P2.09-005 - The C-reactive Protein/Albumin Ratio is a Novel Significant Prognostic Factor in Patients with Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Shinkichi Takamori | Author(s): Gouji Toyokawa, T. Tagawa, F. Kinoshita, Yuka Kozuma, T. Matsubara, Naoki Haratake, Takaki Akamine, F. Hirai, M. Takenoyama, Y. Ichinose, Y. Maehara
- Abstract
Loading... -
+
P2.09-005a - Clinical Characteristics of Early Stage, Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Kozo Kuribayashi | Author(s): Yoshiki Negi, Y. Koda, K. Mikami, T. Minami, T. Yokoi, S. Hasegawa, T. Kijima
- Abstract
Loading... -
+
P2.09-006 - FISH Analysis of p16 and BAP1 Immunohistochemistry for the Diagnosis of Mesothelioma
09:30 - 09:30 | Presenter: Kenzo Hiroshima | Author(s): D. Wu, T. Yusa, D. Ozaki, E. Koh, Yasuo Sekine, R. Haba, K. Washimi, K. Nabeshima, T. Tsujimura
- Abstract
Loading... -
+
P2.09-007 - Pleural Biopsy in Patients Suspected of Malignant Pleural Mesothelioma Consecutive 377 Cases
09:30 - 09:30 | Presenter: Masaki Hashimoto | Author(s): T. Nakamichi, A. Fukuda, A. Kuroda, T. Takuwa, S. Matsumoto, N. Kondo, T. Tsujimura, S. Hasegawa
- Abstract
Loading... -
+
P2.09-008 - Usefulness of Immunohistochemistry in the Differential Diagnosis of Epithelioid Mesothelioma and Lung Squamous Cell Carcinoma
09:30 - 09:30 | Presenter: Kei Kushitani | Author(s): Vishwa Jeet Amatya, Y. Okada, Y. Katayama, A.S. Mawas, Y. Miyata, Morihito Okada, K. Inai, T. Kishimoto, Y. Takeshima
- Abstract
Loading...
-
+
P2.10 - Nursing/Palliative Care/Ethics
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Nursing/Palliative Care/Ethics
-
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.10-003 - The Deterioration and Prognostic Value of Functional Capacity in Patients with Lung Cancer: A Systematic Review
09:30 - 09:30 | Presenter: Laerke Winther | Author(s): Morten Quist
- Abstract
Loading... -
+
P2.10-004 - Efficacy and Safety of Viscum Album (Helixor M) to Treat Malignant Pleural Effusion in Patients with Advanced Lung Cancer
09:30 - 09:30 | Presenter: Yun-Gyoo Lee | Author(s): I. Jung, S. Lee
- Abstract
Loading... -
+
P2.10-005 - Overall Survival of Lung Cancer Patients with Brain Metastases in a Developing Country
09:30 - 09:30 | Presenter: Tomi Kovacevic | Author(s): B. Zaric, D. Bokan
- Abstract
Loading... -
+
P2.10-006 - Prognostic Factors of Mortality and Recurrence of Malignant Pleural Effusion in High-Risk Tumors According to the LENT Score Study
09:30 - 09:30 | Presenter: Fernando Conrado Abrão | Author(s): M.C.D. Oliveira, G.G. Viana, I.R. Abreu, R. Younes, C. Marciano
- Abstract
Loading... -
+
P2.10-007 - Quality of Life across Various Treatment Lines in Metastatic Lung Cancer Patients
09:30 - 09:30 | Presenter: Aseem Rai Bhatnagar | Author(s): P. Kumbhaj, R. Bhandari, R. Sharma
- Abstract
Loading...
-
+
P2.11 - Patient Advocacy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Patient Advocacy
-
+
P2.11-001 - Evaluation of a Cultural Notebook of Self-Expression and Follow-Up Among Patients with Lung Cancer in French Polynesia
09:30 - 09:30 | Presenter: Eric Parrat | Author(s): D. Lutringer-Magnin, P. Barthe-Vonsy, M. Giroud
- Abstract
Loading... -
+
P2.11-002 - To Live and Work with Lung Cancer: Coping Strategies of a Stage 4 Patient
09:30 - 09:30 | Presenter: Satoko Kono | Author(s): T. Yamaoka
- Abstract
Loading...
-
+
P2.12 - Pulmonology/Endoscopy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Pulmonology/Endoscopy
-
+
P2.12-001 - Early Experience with Radial Endobronchial Ultrasound with Guide Sheath For Diagnosis of Peripheral Pulmonary Lesion
09:30 - 09:30 | Presenter: Sze Shyang Kho | Author(s): M.C. Yong, S.K. Chan, S.T. Tie
- Abstract
Loading... -
+
P2.12-002 - Radial Probe Endobronchial Ultrasound (R-EBUS) Guided Transbronchial Cryobiopsy In The Diagnosis of Peripheral Lung Mass
09:30 - 09:30 | Presenter: Sze Shyang Kho | Author(s): M.C. Yong, S.K. Chan, S.T. Tie
- Abstract
Loading... -
+
P2.12-003 - The History of EBUS TBNA
09:30 - 09:30 | Presenter: Mark Krasnik
- Abstract
Loading... -
+
P2.12-004 - Lung Cancer Detection Rate of Conventional Bronchoscopic Techniques: A Tertiary Hospital Experience June 2011- December 2016
09:30 - 09:30 | Presenter: Marlo Pasco Bagano | Author(s): J.C.E. Aranas, M.C. Zanoria
- Abstract
Loading... -
+
P2.12-005 - Comparison of Needle Gauge Used to Obtain Specimens During EBUS-TBNA in Patients with Lung Cancer
09:30 - 09:30 | Presenter: Goohyeon Hong | Author(s): J.H. Koo, D.H. Kim, J.S. Park, Y.S. Kim
- Abstract
Loading... -
+
P2.12-006 - Evaluation of New 25G Needle in EBUS-TBNA Comparing Conventional 22G Needle in Diagnosis for Nodal Metastasis of Lung Cancer
09:30 - 09:30 | Presenter: Yuichi Sakairi | Author(s): Takahiro Nakajima, Y. Yonemori, T. Kaiho, K. Ohashi, Y. Sata, Yuki Shiina, T. Toyoda, A. Hata, H. Tamura, T. Fujiwara, Hironobu Wada, H. Suzuki, M. Chiyo, I. Yoshino
- Abstract
Loading... -
+
P2.12-006a - CT Findings Reduce the Risk of EBUS-TBNA
09:30 - 09:30 | Presenter: K. Kambara | Author(s): R. Hayashi, Z. Setou, T. Hirai, K. Shimokawa, K. Tokui, C. Taka, S. Okazawa, M. Inomata, S. Imanishi, T. Yamada, T. Miwa, S. Matui, K. Tobe, Y. Akemoto, N. Kitamura, T. Homma
- Abstract
Loading...
-
+
P2.13 - Radiology/Staging/Screening
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Radiology/Staging/Screening
-
+
- Abstract
Loading... -
+
P2.13-002 - The LungScreen WA Project: Feasibility of LDCT Screening with the PLCOm2012 Risk Model and PanCan Nodule Risk Calculator
09:30 - 09:30 | Presenter: Kuan Pin Lim | Author(s): D. Manners, B. Adler, S. Melsom, E. Harris, Fraser Brims, A. McWilliams
- Abstract
Loading... -
+
P2.13-004 - Role of Low-Dose Chest Computerized Tomography in Lung Cancer Screening among Never-Smokers
09:30 - 09:30 | Presenter: Hye-Rin Kang | Author(s): C. Lee
- Abstract
Loading... -
+
P2.13-005 - Early Results of Lung Cancer Screening in an African American Population
09:30 - 09:30 | Presenter: Cherie Parungo Erkmen | Author(s): L. Schmidt, Shelby Rebecca Sferra, R.F. Moore, S.K. Randhawa, M. Mitchell, V. Disesa, L.R. Kaiser, G.X. Ma
- Abstract
Loading... -
+
P2.13-006 - Enhanced Shared Decision Making in Lung Cancer Screening: Addressing Questions of Willingness and Ability to Undergo Lung Cancer Treatment
09:30 - 09:30 | Presenter: Cherie Parungo Erkmen | Author(s): Shelby Rebecca Sferra, R.F. Moore, M. Mitchell, V. Disesa, L.R. Kaiser, G.X. Ma
- Abstract
Loading... -
+
P2.13-007 - Relationship of Nodule Count and Lung Cancer Probability in New Nodules Detected after Baseline in CT Lung Cancer Screening
09:30 - 09:30 | Presenter: Joan E Walter | Author(s): M.A. Heuvelmans, R. Vliegenthart, P.M. Ooijen, Harry J De Koning, Matthijs Oudkerk
- Abstract
Loading... -
+
P2.13-008 - Lung Cancer Screening Improves Mortality: Examining Screening Patterns in an Urban Underserved Community
09:30 - 09:30 | Presenter: Haiying Cheng | Author(s): C.T. Su, A. Bhargava, C.D. Shah, Balazs Halmos, R.A. Gucalp, S.H. Packer, N. Ohri, L.B. Haramati, R. Perez-Soler
- Abstract
Loading... -
+
P2.13-009 - Results of Low-Dose CT Lung Cancer Screening at a Non-University Tertiary Hospital System in Oregon, USA
09:30 - 09:30 | Presenter: John R Handy | Author(s): M.D. Skokan, E. Rauch, S. Zinck, R.E. Sanborn, C. Betzer
- Abstract
Loading... -
+
P2.13-010 - Five-Year-Long Follow-Up of the Low-Dose Computed Tomography Screening Programme in Gdansk, Poland
09:30 - 09:30 | Presenter: Marcin Ostrowski | Author(s): Tomasz Marjanski, M. Marczyk, J. Polanska, W. Rzyman
- Abstract
Loading... -
+
P2.13-011 - Optimal Selection Criteria for LDCT Lung Cancer Screening
09:30 - 09:30 | Presenter: Renelle L Myers | Author(s): M. Ruparel, N. Taghizadeh, S. Atkar-Khattra, J. Dickson, S. Quaife, A. Bhowmik, P. Burrowes, P. Maceachern, E. Bedard, J. Yee, J.R. Mayo, J. Liu, Kwun M Fong, C. Berg, M. Tammemägi, A. Tremblay, Sam M Janes, Stephen Lam
- Abstract
Loading... -
+
P2.13-012 - Recruitment for Lung Cancer Screening
09:30 - 09:30 | Presenter: Renelle L Myers | Author(s): S. Atkar-Khattra, J. Yee, J.R. Mayo, J. Liu, A. Dybuncio, M. Tammemägi, Stephen Lam
- Abstract
Loading... -
+
P2.13-013 - Determination of the Detection Lead Time for Autoantibody Biomarkers in Early Stage Lung Cancer Using the UKCTOCS Cohort
09:30 - 09:30 | Presenter: Jim Jett | Author(s): G. Healey, I. Macdonald, C. Parsy-Kowalska, L. Peek, A. Murray
- Abstract
Loading... -
+
P2.13-014 - Computed Tomography-Based Radiomic Classifier Distinguishes Malignant from Benign Pulmonary Nodules in the National Lung Screening Trial
09:30 - 09:30 | Presenter: Tobias Peikert | Author(s): F. Duan, S. Rajagopalan, R. Karwoski, Z. Qin, J. Sicks, R. Clay, R. Robb, B. Bartholmai, Fabien Maldonado
- Abstract
Loading... -
+
P2.13-015 - The Primary Care Provider Role in the US Screening Context: Current Practices and Strategies for Physician Engagement
09:30 - 09:30 | Presenter: Angela Meredith Criswell | Author(s): A. Copeland
- Abstract
Loading... -
+
P2.13-016 - Self-Reported Program Barriers to Increasing Lung Cancer Screening Rates in the US and Implications for the Screening Community
09:30 - 09:30 | Presenter: Angela Meredith Criswell | Author(s): A. Copeland
- Abstract
Loading... -
+
P2.13-017 - Four Years of Data in an Established Low Dose CT (LDCT) Screening Program
09:30 - 09:30 | Presenter: Jacob Sands | Author(s): S.M. Regis, Andrea Katalin Borondy Kitts, K.M. Reiger-Christ, A.B. McKee, B.J. McKee
- Abstract
Loading... -
+
P2.13-018 - Clinical Outcomes Stage I/0 Adenocarcinoma Lung Diagnosed by Low Dose CT (LDCT) Screening vs Incidentally Discovered
09:30 - 09:30 | Presenter: Jacob Sands | Author(s): K.M. Reiger-Christ, T. Sullivan, C. Williamson, E. Burks
- Abstract
Loading... -
+
P2.13-019 - Attrition Rate in Community-Based Lung Cancer Screening: One and Done
09:30 - 09:30 | Presenter: Candice L. Wilshire | Author(s): A.S. Carlson, Joelle Thirsk Fathi, J.R. Rayburn, C.R. Gilbert, S.C. Blanshan, B.E. Louie, R.W. Aye, A.S. Farivar, Eric Vallieres, J.A. Gorden
- Abstract
Loading... -
+
P2.13-020 - Lung-RADS Used in Lung Cancer Screening: Does Granulomatous Disease Intereferes with the Results? Initial Findings at a Brazilian Cancer Center
09:30 - 09:30 | Presenter: Fabio Jose Haddad | Author(s): M.D. Guimaraes, T.C. Chulam, P.N. Barbosa, A. Bitencourt, C.J. Tyng, J. Nochang, J.B. Folador, J.L. Gross
- Abstract
Loading... -
+
P2.13-021 - Community Network Lung Cancer Screening Experience Underrepresents Medically Underserved and Geographically Remote Individuals
09:30 - 09:30 | Presenter: Candice Leigh Wilshire | Author(s): B.M. McCall, C. Fuller, C.R. Gilbert, Joelle Thirsk Fathi, John R Handy, K. Costas, B.E. Louie, R. Aye, A.S. Farivar, Eric Vallieres, J.A. Gorden
- Abstract
Loading... -
+
P2.13-022 - Lung Nodule Survey: One Pathology, Perspectives from Thoracic Surgeon, Pulmonologist and Radiology Point of View
09:30 - 09:30 | Presenter: Maria Teresa Ruiz Tsukazan | Author(s): R.M. Terra, I. Santoro, G. Fortunato, G. Meirelles, Frank Detterbeck
- Abstract
Loading... -
+
P2.13-023 - Lung Cancer Risk and Eligibility for Lung Cancer Screening in Patients Undergoing Computed Tomography Coronary Angiography
09:30 - 09:30 | Presenter: Daniel P Steinfort | Author(s): S. Zaw, B. King, S. Joshi, O. Farouque, A. Al-Kaisey, D.F. Johnson, L.B. Irving, D. Manners, Katharine See
- Abstract
Loading... -
+
P2.13-025 - Selecting the Risk Cut off for the LLP Model
09:30 - 09:30 | Presenter: Kevin Ten Haaf | Author(s): Harry J De Koning, John Kirkpatrick Field
- Abstract
Loading... -
+
P2.13-026 - Determining the Effect of Screening on Lung Cancer Mortality
09:30 - 09:30 | Presenter: Claudia I Henschke | Author(s): S. Tuminello, B. Liu, W. Lieberman-Cribbin, David F Yankelevitz, R. Flores, E. Taioli
- Abstract
Loading... -
+
P2.13-026a - A Validated Clinical Lung Cancer Risk-Prediction Model for Light-, Heavy- and Ex-Smokers: the Lung-HUNT Model
09:30 - 09:30 | Presenter: Oluf Dimitri Røe | Author(s): M. Markaki, I. Tsamardinos, A. Langhammer, V. Lagani, K. Hveem
- Abstract
Loading... -
+
P2.13-026b - A Novel Ultra Low Cost CT Image Quality Measurement Device
09:30 - 09:30 | Presenter: Ricardo S Avila | Author(s): R. Subramanian, David F Yankelevitz
- Abstract
Loading... -
+
P2.13-026c - Impact of Lung Cancer Multidisciplinary Meeting Presentation on Quality of Life and Survival: A Victorian Retrospective Cohort Study
09:30 - 09:30 | Presenter: Rob Stirling | Author(s): A. Rischin, A. Earnest, M. Brand, J.H. Gooi, J.D. Ruben, M. Moore, S. Ellis, M. Cherk, C. Li, L. Mansfield, H. Mott, C. McLean, S.M. Evans
- Abstract
Loading...
-
+
P2.14 - Radiotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Radiotherapy
-
+
P2.14-001 - Mid-Treatment Perfusion PET/CT Is More Effective Than Ventilation PET/CT in Functionally-Adapted Radiotherapy for NSCLC
09:30 - 09:30 | Presenter: Roshini Thomas | Author(s): Guy-Anne Turgeon, M. Hofman, J. Callahan, N. Anderson, N. Hardcastle, T. Kron, M. Bressel, Daniel P Steinfort, M. Shaw, N. Plumridge, M.P. Macmanus, R. Hicks, David L Ball, S. Siva
- Abstract
Loading... -
+
P2.14-002 - Impact of Pre-Existing Cardiac Disease and Heart Doses on Survival in Nsclc Treated with Post-Operative Thoracic Radiotherapy
09:30 - 09:30 | Presenter: Chia Ching Lee | Author(s): H. Zheng, Y.Y. Soon, B. Vellayappan, Wee Yao Koh, C.N. Leong, J. Tey, Ivan WK Tham
- Abstract
Loading... -
+
P2.14-003 - Clinical Outcomes of SBRT in Inoperable Elderly Patients with NSCLC: Experience from a Developing Country
09:30 - 09:30 | Presenter: Fabio Y Moraes | Author(s): C.E. Abreu, F.A. Miranda, G.S. Siqueira, R. Gadia, C.K. Haddad, H.A. Carvalho
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.14-005 - Determination of Optimal Cut off SUV Threshold for Auto-Contouring of GTV Using PETCT for Early Stage NSCLC
09:30 - 09:30 | Presenter: Mangesh Babarao Patil | Author(s): J.P. Agarwal, N. Purandare, S.G. Laskar, V. Rangrajan, A. Tibdewal, A. Chatterji, N. Mummudi, C.S. Pramesh, R. Kumar, A. Jha, S. Misra
- Abstract
Loading... -
+
P2.14-006 - A Pilot, Randomized Trial of Daily Lisinopril vs Placebo to Prevent Radiation-Induced Pulmonary Distress (Alliance MC1221)
09:30 - 09:30 | Presenter: Terence Tai Weng Sio | Author(s): P.J. Atherton, W.K. Zhen, Y.I. Garces, D.J. Ma, S. Van Der Veen, Apar Kishor Ganti, S.E. Schild, R.C. Miller
- Abstract
Loading... -
+
P2.14-007 - Histological Difference in Outcomes of Definitive Chemoradiotherapy for non-small cell Lung Cancer
09:30 - 09:30 | Presenter: Ito Hitoshi | Author(s): Yukinori Matsuo, S. Ohtsu, T. Sakamoto, T. Mizowaki
- Abstract
Loading... -
+
P2.14-008 - Partial and Full Arc VMAT in Lung Cancer SBRT with Different Definitions of Internal Target Volume Based on 4D CT
09:30 - 09:30 | Presenter: Xiance Jin | Author(s): Congying Xie
- Abstract
Loading... -
+
P2.14-009 - Assessing the Value of Radiotherapy for Lung Cancer in the Intensive Care Unit – A Population-based analysis
09:30 - 09:30 | Presenter: Alexander Vincent Louie | Author(s): L. Li, K. Bray Jenkyn, B. Allen, A. Warner, G.B. Rodrigues, D.A. Palma, S. Shariff
- Abstract
Loading... -
+
P2.14-010 - The Time-Weighted Mid-Ventilation Technique: Reducing Planning Target Volumes For Patients Undergoing Lung Stereotactic Body Radiotherapy.
09:30 - 09:30 | Presenter: Charlotte Emily Louise Atkinson | Author(s): J. Yuen, J. Poder, E. Hau, Y. Chin
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.14-012 - Clinical Outcomes of the Largest UK Cohort of Cyberknife-Delivered Stereotactic Ablative Body Radiotherapy (SABR) for Primary Lung Cancers
09:30 - 09:30 | Presenter: Qamar Ghafoor | Author(s): S. Mascall, B. Allos, M. Vreugdenhil, S. Watkins, R. Stevenson
- Abstract
Loading... -
+
P2.14-013 - Effect of Stereotactic Radiotherapy (SABR) on Pulmonary Function and Quality of Life: Results from a Tertiary Oncology Unit
09:30 - 09:30 | Presenter: Qamar Ghafoor | Author(s): C.M.N. Gray, E. Wingate
- Abstract
Loading... -
+
P2.14-014 - Does Histological Subtype Affect Outcomes in Stereotactic Ablative Body Radiotherapy (SABR) for Lung Tumours?
09:30 - 09:30 | Presenter: Qamar Ghafoor | Author(s): B. Allos, S. Mascall, M. Vreugdenhil, S. Watkins, R. Stevenson
- Abstract
Loading... -
+
P2.14-015 - Outcomes for Stereotactic Ablative Body Radiotherapy (SABR) for Early Primary Lung Cancers: Cyberknife Versus VMAT Platform
09:30 - 09:30 | Presenter: Qamar Ghafoor | Author(s): B. Allos, S. Mascall, M. Vreugdenhil, S. Watkins, R. Stevenson
- Abstract
Loading... -
+
P2.14-016 - Pulomonary Resection After Curative Intent Chemoradiation for NSCLC
09:30 - 09:30 | Presenter: Gamze Cetinkaya | Author(s): Huseyin Melek, B. Özkan, E. Özer, S. Sarıhan, E. Yentürk, T. Sevinç, A.S. Bayram, A. Toker, Cengiz Gebitekin
- Abstract
Loading... -
+
P2.14-017 - Postoperative Radiotherapy in Completely Resected Stage IIIA-N2 Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Sung-Ja Ahn | Author(s): K. Na, Young-Chul Kim, S. Song, In-Jae Oh, C. Park
- Abstract
Loading... -
+
P2.14-018 - Treatment Outcome and Lung Toxicities of Volumetric Modulated Arc Therapy in the Treatment of Inoperable Non-Small-Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Congying Xie | Author(s): Xiance Jin
- Abstract
Loading... -
+
P2.14-019 - Magnetic Resonance (MR)-Guided Adaptive Stereotactic Ablative Radiotherapy for Adrenal Metastases
09:30 - 09:30 | Presenter: Suresh Senan | Author(s): M. Palacios, O. Bohoudi, A. Bruynzeel, B. Slotman, F.J. Lagerwaard
- Abstract
Loading... -
+
P2.14-020 - Clinical Validation of NTCP-Models for Esophagus Toxicity in Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiation
09:30 - 09:30 | Presenter: Iris Walraven | Author(s): Margriet Kwint, S. Marshall, M. Verheij, J. Belderbos, T. Janssen
- Abstract
Loading... -
+
P2.14-020a - Retrospective Research on Radiofrequency Ablation (RFA) for Liver Metastasis Due to NSCLC: A Single Institutional Experience
09:30 - 09:30 | Presenter: Kentaro Ito | Author(s): M. Kuroda, Yuki Nakamura, Y. Suzuki, H. Saiki, T. Sakaguchi, Y. Nishii, F. Watanabe, O. Hataji
- Abstract
No abstract available for this presentation
-
+
P2.14-020b - Prognostic factors in unresectable stage III NSCLC treated with concurrent chemoradiotherapy
09:30 - 09:30 | Presenter: Kenneth Obyrne | Author(s): P. Kalokerinos, C. Morton, T. Mai, M. McGrath, M. Lehman, E. McCaffrey
- Abstract
Loading...
-
+
P2.15 - SCLC/Neuroendocrine Tumors
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: SCLC/Neuroendocrine Tumors
-
+
P2.15-001 - NHWD-870, a Novel BET Family Bromodomain Inhibitor Targeting BRD2/3/4, Proved to Be Effective and Promising for Treatment of Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Yongchang Zhang | Author(s): N. Yang
- Abstract
Loading... -
+
P2.15-002 - Pulmonary Large Cell Neuroendocrine Carcinoma (LCNEC): An Experience From Eastern Indian Hospital
09:30 - 09:30 | Presenter: Prasanta Raghab Mohapatra | Author(s): S. Patra, S. Bhuniya, M.K. Panigrahi, P. Mishra, S. Purkait, S. Mohakud, S. Naik, S. Sahoo, S.K. Jagaty, S. Mohankudo, Y. Dhanurdhar, S.K. Das Majumdar, M. Kar
- Abstract
Loading... -
+
P2.15-003 - A Long Non-Coding RNA HOTTIP Expression Is Associated with Disease Progression and Predicts Outcome in Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Linlang Guo | Author(s): Y. Sun, Qiongyao Wang, J. Bao, Fanrui Zeng
- Abstract
Loading... -
+
P2.15-004 - Underrepresentation of Elderly Patients with ED-SCLC as Clinical Trial Candidates (JCOG1201/TORG1528)
09:30 - 09:30 | Presenter: Yuki Misumi | Author(s): Tsuneo Shimokawa, Hiroaki Okamoto, Shinji Atagi, H. Tanaka, Koichi Goto, Kazuhiko Nakagawa, T. Hida, Nobuyuki Yamamoto, Y. Hosomi, Terufumi Kato, Isamu Okamoto, Yuichiro Ohe
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.15-006 - The Effects of Pegylated Arginase on Small Cell Lung Cancer in vitro and in vivo
09:30 - 09:30 | Presenter: Shi Xu | Author(s): Sze Kwan Lam, P.N. Cheng, J.C. Ho
- Abstract
Loading... -
+
P2.15-007 - Extensive Stage Small Cell Lung Cancer: Patterns of Care and Outcomes of a Single Institution over 15 Years
09:30 - 09:30 | Presenter: Eunji Hwang | Author(s): C.R. Lewis, J. Williams, W. Wong
- Abstract
Loading... -
+
P2.15-008 - Genomic Analysis to Assess a Molecular Signature in Japanese Patients with Pulmonary High Grade Neuroendocrine Carcinoma
09:30 - 09:30 | Presenter: Hideaki Kojima | Author(s): M. Serizawa, S. Takahashi, M. Isaka, Akira Ono, T. Nagashima, S. Ohnami, K. Ohshima, K. Urakami, M. Kusuhara, T. Sugino, T. Takahashi, K. Yamaguchi, Y. Ohde
- Abstract
Loading... -
+
P2.15-009 - Linc00173 Modulates Chemoresistance of Small Cell Lung Cancer by Functioning as a Competing Endogenous RNA to Regulate Etk Expression
09:30 - 09:30 | Presenter: Fanrui Zeng | Author(s): Q. Wang, L. Guo, S. Wang, W. Huang
- Abstract
Loading... -
+
P2.15-010 - Etk Interacting with PFKFB4 Modulates Chemoresistance of Small Cell Lung Cancer by Regulating Autophagy
09:30 - 09:30 | Presenter: Qiongyao Wang | Author(s): Fanrui Zeng, Y. Sun, Q. Qiu, J. Zhang, L. Guo
- Abstract
Loading... -
+
P2.15-011 - Therapeutic Strategies and Genetic Comparisons in SCLC and LCNEC of the Lung Using Next-Generation Sequencing
09:30 - 09:30 | Presenter: Masaoki Ito | Author(s): Y. Miyata, S. Hirano, S. Kimura, F. Irisuna, Kei Kushitani, Yasuhiro Tsutani, Y. Takeshima, Morihito Okada
- Abstract
Loading... -
+
P2.15-012 - Analysis of Small Cell Lung Cancer with Paraneoplastic Limbic Encephalitis
09:30 - 09:30 | Presenter: Mingyi Di
- Abstract
Loading... -
+
P2.15-013 - Doxorubicin and Topotecan for Relapsed/Refractory Small Cell Lung Cancer (SCLC): A FPBCC Clinical Trials Network Phase I Study
09:30 - 09:30 | Presenter: Apar Kishor Ganti | Author(s): J. Manikkam Umakanthan, A. Marr, V. Ernani, M.A. Kessinger, L.M. Smith, J.M. Tijerina, S. Radniecki, E. Kosmacek, M. Ketcham
- Abstract
Loading... -
+
P2.15-014 - Extensive Stage Small Cell Lung Cancer: Is Primary Growth Factor Support Warranted in Patients Having Doublet Chemotherapy?
09:30 - 09:30 | Presenter: Tasha Mackie | Author(s): C. Jacobs
- Abstract
Loading... -
+
P2.15-015 - Negativity for Thyroid Transcription Factor 1 Was Correlated with Less Neuroendocrine Differentiation in Small Cell Lung Cancers
09:30 - 09:30 | Presenter: Yuko Iida | Author(s): N. Takahashi, Yoko Nakanishi, H. Nishimaki, Yoshiko Nakagawa, T. Shimizu, K. Mizumura, S. Maruoka, Y. Gon, S. Masuda, S. Hashimoto
- Abstract
Loading... -
+
P2.15-016 - Clinical Significance of Topoisomerase-II Expression in Patients with Relapsed HGNEC of the Lung Treated with Amrubicin
09:30 - 09:30 | Presenter: Yosuke Miura | Author(s): K. Kaira, Reiko Sakurai, Y. Tomizawa, Y. Tsukagoshi, T. Masuda, Norimitsu Kasahara, N. Sunaga, R. Saito, T. Hisada
- Abstract
Loading... -
+
P2.15-016a - Exploiting G2-M Cell Cycle Checkpoint Dependency in Small Cell Lung Cancer (SCLC) by Targeting Checkpoint Kinase 1 (CHK1)
09:30 - 09:30 | Presenter: Triparna Sen | Author(s): P. Tong, C..A. Stewart, S. Cristea, A. Valliani, D.S. Shames, A.B. Redwood, Y. Fan, L. Li, B. Glisson, J. Minna, Julien Sage, Don Lynn Gibbons, H. Piwnica-Worms, John V Heymach, J. Wang, L.A. Byers
- Abstract
No abstract available for this presentation
-
+
P2.16 - Surgery
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Surgery
-
+
P2.16-001 - Liposomal Bupivacaine (Exparel) Reduces Thoracic Surgery Post-Operative Pain and Reduces Length of Stay, a Retrospetive Study
09:30 - 09:30 | Presenter: Joseph Aisner | Author(s): J. Langenfeld, R. Nemoyer, J. Crystal, S. Mellender, A. Chiricolo, R. Jongco, E. Anton
- Abstract
Loading... -
+
P2.16-002 - Adequacy of Lymph Node Sampling during Lobectomy in a Small Community Teaching Hospital
09:30 - 09:30 | Presenter: Mark A Kryskow | Author(s): R. Knowles, V. Rivera, C. Galvez
- Abstract
Loading... -
+
P2.16-003 - Diagnostic Lobectomy for Indeterminate Pulmonary Tumor
09:30 - 09:30 | Presenter: Noritoshi Nishiyama | Author(s): N. Izumi, T. Tsukioka, K. Tei, H. Komatsu, M. Toda, K. Hara, H. Miyamoto
- Abstract
Loading... -
+
P2.16-004 - Alternative Subpreural Lymph Flow Pathways in Human Lung – a Hundred Cases Experience and Analysis
09:30 - 09:30 | Presenter: Takuya Tokunaga | Author(s): A.H. Takeda, Y. Watanabe, T. Umehara, S. Suzuki, G. Kamimura, K. Maeda, Masaya Aoki, T. Nagata, Tsunayuki Otsuka, N. Yokomakura, K. Kariatsumari, K. Sakasegawa, Yoshihiro Nakamura, M. Yanagi, Masami Sato
- Abstract
Loading... -
+
P2.16-005 - Is There Any Oncological Concern about Preoperative Biopsy for Resectable Lung Cancer Patients?
09:30 - 09:30 | Presenter: Hideyuki Kozuka | Author(s): Y. Taniguchi, K. Fukumoto, H. Matsui, T. Saito, T. Murakawa
- Abstract
Loading... -
+
P2.16-006 - Locking of the Scapula after Lobectomy with Rib Resection
09:30 - 09:30 | Presenter: Motohiro Nishimura | Author(s): Hirofumi Suzuki
- Abstract
Loading... -
+
P2.16-007 - Two Cases of VATS Resection for Endobronchial Protruded Tumors
09:30 - 09:30 | Presenter: Kunihiko Terauchi
- Abstract
Loading... -
+
P2.16-008 - Collapsed Lung Index Ten Minutes after Thoracotomy and Pre-Operative Pulmonary Function Tests
09:30 - 09:30 | Presenter: Junichi Shimada | Author(s): Kazuhiro Ito, Motohiro Nishimura, Y. Iwasaki, Hirofumi Suzuki
- Abstract
Loading... -
+
P2.16-009 - Strategy for Oncologic Emergency in Thoracic Disease
09:30 - 09:30 | Presenter: Ryohei Yoshikawa | Author(s): N. Kawatani, M. Kamiyoshihara, Hitoshi Igai, T. Ibe, F. Osawa
- Abstract
Loading... -
+
P2.16-010 - Removing the Chest Tube on the First Day after Surgery Does Not Contribute to the Early Discharge from the Hospital
09:30 - 09:30 | Presenter: Takuya Ohashi | Author(s): Tatsuya Yoshimasu, M. Kawago, Y. Hirai, M. Miyasaka, Y. Yata, Y. Aoishi, S. Oura, Y. Nishimura
- Abstract
Loading... -
+
P2.16-011 - Unsuspectedly Detected Isolated Fibrinogen Deficiency in a Patient with Lung Adenocarcinoma after Surgery
09:30 - 09:30 | Presenter: Jeong Su Cho | Author(s): Y.D. Kim, H.Y. Ahn, H. I, J. Son
- Abstract
Loading... -
+
P2.16-012 - Does Percutaneous Ultrasound Predict Tumor Site and Internal Tumor Properties?
09:30 - 09:30 | Presenter: Gaku Yamaguchi | Author(s): C. Konaka, Norihiko Ikeda
- Abstract
Loading... -
+
P2.16-013 - Peripheral or Central Lung Nodules: How do Thoracic Surgeons Define it?
09:30 - 09:30 | Presenter: Rowena Yip | Author(s): K. Li, Claudia I Henschke, David F Yankelevitz
- Abstract
Loading... -
+
P2.16-014 - Deconstructing Surgical Decision Making
09:30 - 09:30 | Presenter: Rowena Yip | Author(s): K. Li, Claudia I Henschke, David F Yankelevitz
- Abstract
Loading... -
+
P2.16-015 - Log Data of Digital Drainage System Is a Potential Predictive Factor of Pleurodesis Efficacy for Postoperative Air Leak After Pulmonary Resection
09:30 - 09:30 | Presenter: Tomonari Oki | Author(s): Keiju Aokage, T. Miyoshi, K. Tane, M. Tsuboi
- Abstract
Loading... -
+
P2.16-016 - Surgical Treatment of Indeterminate Lung Nodules
09:30 - 09:30 | Presenter: Masashi Yanada | Author(s): Y. Matsuura, M. Inoue
- Abstract
Loading... -
+
P2.16-017 - Surgical Treatment of Bronchial Carcinoid Tumors: Evaluation of Survival and Prognostic Factors. A Single-Center Experience
09:30 - 09:30 | Presenter: Piotr Rudzinski | Author(s): Renata Langfort, M. Szolkowska, T. Orlowski
- Abstract
Loading... -
+
P2.16-018 - Phrenic Nerve Injury After Lung Surgery: An Underestimated Problem
09:30 - 09:30 | Presenter: Luigi Ventura | Author(s): W. Zhao, T. Chen, Z. Wang, J. Feng, C. Ji, Wentao Fang
- Abstract
Loading... -
+
P2.16-019 - Improving Survival with a Lymph Node (LN) Collection Kit for Non-Small Cell Lung Cancer (NSCLC) Resections
09:30 - 09:30 | Presenter: Raymond U. Osarogiagbon | Author(s): N.R. Faris, Matthew P Smeltzer, C. Fehnel, C. Houston-Harris, P. Ojeabulu, O. Akinbobola, M.A. Ray, Y. Lee, L. Deese, E. Owen, B. Wolf, H.L. Wiggins, C. Mutrie, V. Sachdev, P. Levy, R.S. Signore, E.T. Robbins
- Abstract
Loading... -
+
P2.16-020 - Surgical Strategy for Synchronous Multiple Lung Cancer with Ground Glass Opacity
09:30 - 09:30 | Presenter: Toshihiko Moroga | Author(s): D. Hamatake, A. Iwasaki, T. Maekawa
- Abstract
Loading... -
+
P2.16-021 - Malignant Melanocytic Neoplasm: A Rare Presentation of a Large Mediastinal Mass
09:30 - 09:30 | Presenter: Tina Koh
- Abstract
Loading... -
+
P2.16-022 - Initiative for Early Lung Cancer Research on Treatment: Pilot Implementation
09:30 - 09:30 | Presenter: Claudia I Henschke | Author(s): R. Flores, E. Taioli, David F Yankelevitz, Rowena Yip, B. Becker, Artit Jirapatnakul, Anthony Reeves, R. Schwartz, K. Tam
- Abstract
Loading... -
+
P2.16-023 - Changes of the Pulmonary Artery After Resection of Stage I Lung Cancer
09:30 - 09:30 | Presenter: Michael Chung | Author(s): E. Lewis, Rowena Yip, Artit Jirapatnakul, Anthony Reeves, David F Yankelevitz, Claudia I Henschke, F. Bhora
- Abstract
Loading... -
+
P2.16-024 - Effect of Resection of Stage 1 Lung Cancer on Lung Volume
09:30 - 09:30 | Presenter: Artit Jirapatnakul | Author(s): Anthony Reeves, Rowena Yip, S. Liu, Y. Xie, R. Flores, Claudia I Henschke, David F Yankelevitz
- Abstract
Loading... -
+
P2.16-025 - Accuracy of Multidisciplinary Evaluation of Small Solitary Pulmonary Nodules in a Portuguese Private Hospital
09:30 - 09:30 | Presenter: Joao Reis | Author(s): M.O. Fernandes, M.M. Felizardo, M. Grafino, A. Catarino, F. Mascarenhas, C. Loewenthal, M. Pantarotto, F. Martelo
- Abstract
Loading... -
+
P2.16-026 - Surgical Treatment for Metastatic Lung Tumors from Various Sarcomas
09:30 - 09:30 | Presenter: Hiromasa Yamamoto | Author(s): K. Namba, K. Takahashi, J. Soh, K. Shien, T. Kurosaki, S. Ohtani, S. Sugimoto, M. Yamane, T. Oto, Shinichi Toyooka
- Abstract
Loading... -
+
P2.16-027 - Comparison of Single Chest Tube Versus Double Chest Tube Drainage After Lung Resection for the Treatment of Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Tomasz Gil | Author(s): Z. Grochowski, J. Warmus, W. Gocyk, B. Staniec, K. Bederski, P. Kocoń, J. Włodarczyk, P. Hajder, B. Kołodziejczyk, J. Kużdżał
- Abstract
Loading... -
+
P2.16-028 - Are We Doing the Right Thing? Overall Survival & Intermediate Outcomes Following Lung Metastasectomy
09:30 - 09:30 | Presenter: Prakash Balakrishnan | Author(s): G. Tinawi, S. Galvin
- Abstract
Loading... -
+
P2.16-028a - Why Are Indigenous New Zealanders Not Getting Surgery (WINGS) : An Audit of Māori Lung Cancer Patients
09:30 - 09:30 | Presenter: William Thompson | Author(s): Anne Fraser, L. Cameron
- Abstract
Loading...